N-Nitroso Tadalafil
Synchemia is a leading Manufacturer in pharmaceutical Nitrosamine compounds. Tadalafil is used to treat men who have erectile dysfunction (also called sexual impotence). Tadalafil belongs to a group of medicines called phosphodiesterase 5 (PDE5) inhibitors. These medicines prevent an enzyme called phosphodiesterase type-5 from working too quickly.Tadalafil Nitroso Impurity 1 is a highly toxic organic compound and a suspected human carcinogen. Handle the material carefully with proper safety measures.
N-Nitroso Tadalafil or Tadalafil Nitroso Impurity 1 CAS NO:NA also known as N-Nitroso Tadalafil Impurity Chemically represented as (6R,12aR)-6-(Benzo[d][1,3]dioxol-5-yl)-2-methyl-7-nitroso-2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione . Synchemia is the leading manufacturing and exporter of Tadalafil Nitroso Impurity 1 . We supply Tadalafil Nitroso Impurity 1 with detailed characterization data compliance with regulatory guidelines.
Make an Enquiry for Abacavir EP Impurity A
Related Products
| CAT No | SRC-N0142595 |
| CAS No | NA |
| Mol.F. | C16H26N2O4 |
| Mol.Wt. | 310.39 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142596 |
| CAS No | NA |
| Mol.F. | C13H20N2O4 |
| Mol.Wt. | 268.31 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142597 |
| CAS No | NA |
| Mol.F. | C19H29N3O5 |
| Mol.Wt. | 379.46 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142598 |
| CAS No | NA |
| Mol.F. | C11H15N3O4 |
| Mol.Wt. | 253.26 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142599 |
| CAS No | NA |
| Mol.F. | C12H13N3O5 |
| Mol.Wt. | 279.25 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142600 |
| CAS No | NA |
| Mol.F. | C18H27N3O3 |
| Mol.Wt. | 333.43 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142601 |
| CAS No | NA |
| Mol.F. | C19H31N3O4 |
| Mol.Wt. | 365.47 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142602 |
| CAS No | NA |
| Mol.F. | C22H36N2O9 |
| Mol.Wt. | 472.54 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142603 |
| CAS No | NA |
| Mol.F. | C8H11N3O2 |
| Mol.Wt. | 181.20 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142604 |
| CAS No | NA |
| Mol.F. | C15H19N4O |
| Mol.Wt. | 271.34 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142605 |
| CAS No | NA |
| Mol.F. | C9H11N3O |
| Mol.Wt. | 177.21 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142606 |
| CAS No | NA |
| Mol.F. | C8H11N3O |
| Mol.Wt. | 165.20 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142607 |
| CAS No | 151512-14-0 |
| Mol.F. | C6H12N4O3 |
| Mol.Wt. | 188.2 g/mol |
| INV STATUS | UNDER SYNTHESIS |
| CAT No | SRC-N0142608 |
| CAS No | NA |
| Mol.F. | C32H45N5O4 |
| Mol.Wt. | 563.74 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142609 |
| CAS No | NA |
| Mol.F. | C24H26N4O4 |
| Mol.Wt. | 434.50 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |
| CAT No | SRC-N0142610 |
| CAS No | NA |
| Mol.F. | C14H13N3O2 |
| Mol.Wt. | 255.28 g/mol |
| INV STATUS | CUSTOM SYNTHESIS |